Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Diseases

  Free Subscription


3 AJR Am J Roentgenol
1 Am J Gastroenterol
2 Biochem Biophys Res Commun
1 BMC Gastroenterol
2 Endoscopy
2 Eur J Pediatr
3 Gut
2 Hepatology
2 J Gastroenterol Hepatol
3 J Hepatol
2 J Pediatr
1 Minerva Gastroenterol (Torino)
1 Radiology
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

    Reply to "Underdiagnosis of High-Risk Liver Diseases Leads to Inadequate Ultrasound Screening for Hepatocellular Carcinoma".
    AJR Am J Roentgenol. 2022 Oct 12:2. doi: 10.2214/AJR.22.28134.

  2. KUO SE, Lin YJ, Wang JD
    Underdiagnosis of High-Risk Liver Diseases Leads to Inadequate Ultrasound Screening for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Oct 12:1-2. doi: 10.2214/AJR.22.28079.

  3. GIAN RK
    Editorial Comment: An Algorithm to Distinguish Between Hepatocellular Adenoma Subtypes on Gadoxetate Disodium-Enhanced MRI.
    AJR Am J Roentgenol. 2022 Oct 12. doi: 10.2214/AJR.22.28613.

    Am J Gastroenterol

  4. CARUSO S, Miraglia R, Alonzo L, Farinella M, et al
    A Rare Portopulmonary Arteriovenous Fistula in a Cirrhotic Patient with Portal Hypertension and Inversion of Blood Flow after Liver Transplantation.
    Am J Gastroenterol. 2022 Oct 6. pii: 00000434-990000000-00541.

    Biochem Biophys Res Commun

  5. TU H, Yin X, Wen J, Wu W, et al
    Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism.
    Biochem Biophys Res Commun. 2022;634:1-9.
    PubMed         Abstract available

  6. ZHAO S, Liu X, Li L, Kong X, et al
    KIRA8 attenuates non-alcoholic steatohepatitis through inhibition of the IRE1alpha/XBP1 signalling pathway.
    Biochem Biophys Res Commun. 2022;632:158-164.
    PubMed         Abstract available

    BMC Gastroenterol

  7. QIU C, Xie S, Sun Y, Yu Y, et al
    Multi-parametric magnetic resonance imaging of liver regeneration in a standardized partial hepatectomy rat model.
    BMC Gastroenterol. 2022;22:430.
    PubMed         Abstract available


  8. HIJIOKA S, Sakamoto Y, Nagashio Y, Maruki Y, et al
    Troubleshooting for endoscopic ultrasound-guided hepaticogastrostomy stent migration: Additional stenting by the partial stent-in-stent method.
    Endoscopy. 2022 Oct 14. doi: 10.1055/a-1941-8357.

  9. OHNO A, Fujimori N, Abe T, Nakamura M, et al
    Bile peritonitis after placement of a metallic stent in endoscopic ultrasound-guided hepaticogastrostomy: A pitfall and the rescue technique.
    Endoscopy. 2022 Oct 10. doi: 10.1055/a-1937-9781.

    Eur J Pediatr

  10. WU B, Zhou Y, Tian X, Cai W, et al
    Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia.
    Eur J Pediatr. 2022 Sep 12. pii: 10.1007/s00431-022-04612.
    PubMed         Abstract available

  11. BALESTRA E, Traunero A, Barbi E
    Investigating the role of Vitamin D in NAFLD: is liver biopsy justifiable in children?
    Eur J Pediatr. 2022;181:3985.


  12. KASPER P, Lang S, Demir M, Steffen HM, et al
    Optimising the management of cardiovascular comorbidities in NAFLD patients: it's time to (re-) act!
    Gut. 2022;71:2365-2366.

  13. BELLOMO G, Rainer C, Quaranta V, Astuti Y, et al
    Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis.
    Gut. 2022 Jan 12. pii: gutjnl-2021-325272. doi: 10.1136/gutjnl-2021-325272.
    PubMed         Abstract available

  14. DUFOUR JF, Marjot T, Becchetti C, Tilg H, et al
    COVID-19 and liver disease.
    Gut. 2022;71:2350-2362.
    PubMed         Abstract available


  15. LAM YK, Yu J, Huang H, Ding X, et al
    TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk.
    Hepatology. 2022 Oct 11. doi: 10.1002/hep.32802.
    PubMed         Abstract available

  16. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
    Diversity, equity, and inclusion in gastroenterology and hepatology: A survey of where we stand.
    Hepatology. 2022 Oct 11. doi: 10.1002/hep.32757.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  17. SARAIVA RO, Gamelas V, Canha MI, Carvalho D, et al
    Hepatobiliary and Pancreatic: An unusual cause of biliary obstruction.
    J Gastroenterol Hepatol. 2022 Oct 10. doi: 10.1111/jgh.16009.

  18. HOU G, Xu W, Ding D, Tian T, et al
    Metabolome and Transcriptome Integration Reveals Metabolic Profile of Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2022 Oct 8. doi: 10.1111/jgh.16024.
    PubMed         Abstract available

    J Hepatol

  19. LI T, Lu Z
    Factor VIII as a potential predictor of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis.
    J Hepatol. 2022 Oct 11. pii: S0168-8278(22)03136.

  20. PERICAS JM, Tacke F, Anstee QM, Di Prospero NA, et al
    Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons.
    J Hepatol. 2022 Oct 7. pii: S0168-8278(22)03131.
    PubMed         Abstract available

  21. TSAI PC, Kuo HT, Hung CH, Tseng KC, et al
    Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
    J Hepatol. 2022 Oct 5. pii: S0168-8278(22)03129.
    PubMed         Abstract available

    J Pediatr

  22. PIASTRA M, Morena TC, Ferrari V, Staccioni M, et al
    Delayed Skin and Airway Injury Associated with Liquid Trichloroethylene.
    J Pediatr. 2022;249:115-116.

  23. SALVI PS, Fawaz R, Cowles RA
    Comparing Serum Matrix Metalloproteinase-7 in Parenteral Nutrition-Associated Liver Disease and Biliary Atresia.
    J Pediatr. 2022 Jun 14. pii: S0022-3476(22)00547.
    PubMed         Abstract available

    Minerva Gastroenterol (Torino)

  24. NICOLOSI A, Gaia S, Risso A, Rosso C, et al
    Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
    Minerva Gastroenterol (Torino). 2022 Oct 12. pii: S2724-5985.21.03006.
    PubMed         Abstract available


  25. KITAO A, Matsui O, Zhang Y, Ogi T, et al
    Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
    Radiology. 2022 Oct 11:220531. doi: 10.1148/radiol.220531.
    PubMed         Abstract available


  26. ZOU Z, Shang R, Zhou L, Du D, et al
    The Novel MyD88 Inhibitor TJ-M2010-5 Protects Against Hepatic Ischemia-reperfusion Injury by Suppressing Pyroptosis in Mice.
    Transplantation. 2022 Oct 12. pii: 00007890-990000000-00172.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.